1. 324 Tralokinumab provides progressive and sustained efficacy in adolescents with moderate-to-severe atopic dermatitis: a post-hoc analysis of the ECZTRA 6 trial. (25th January 2023) Authors: Simpson, Eric L; Wollenberg, Andreas; Kurbasic, Azra ; Tindberg, Ann-Marie; Soldbro, Lise ; Paller, Amy S Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 330 Safety of abrocitinib in 3582 patients with moderate-to-severe atopic dermatitis with over 900 patients exposed for almost 2 years. (25th January 2023) Authors: Simpson, Eric L; Silverberg, Jonathan I; Nosbaum, Audrey; Winthrop, Kevin; Guttman-Yassky, Emma; Hoffmeister, Karin M; Egeberg, Alexander; Valdez, Hernan; Fan, Haiyun; Farooqui, Saleem A; Chan, Gary; Alderfer, Justine; Romero, William; Johnson, Susan Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 359 Switching from dupilumab to abrocitinib in patients with moderate-to-severe atopic dermatitis: an analysis of responders and nonresponders to dupilumab. (25th January 2023) Authors: Silverberg, Jonathan I; Simpson, Eric L; Thyssen, Jacob P ; Pink, Andrew E; Weidinger, Stephan ; Chan, Gary; Lazariciu, Irina; Clibborn, Claire; Guler, Erman Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Abrocitinib for atopic dermatitis – Authors' reply. Issue 10270 (16th January 2021) Authors: Simpson, Eric L; Bieber, Thomas; Thyssen, Jacob P; Valdez, Hernan; Rojo, Ricardo Journal: Lancet Issue: Volume 397:Issue 10270(2021) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study. Issue 10372 (21st January 2023) Authors: Guttman-Yassky, Emma; Simpson, Eric L; Reich, Kristian; Kabashima, Kenji; Igawa, Ken; Suzuki, Tetsuya; Mano, Hirotaka; Matsui, Takeshi; Esfandiari, Ehsanollah; Furue, Masutaka Journal: Lancet Issue: Volume 401:Issue 10372(2023) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. Issue 10228 (21st March 2020) Authors: Chalmers, Joanne R; Haines, Rachel H; Bradshaw, Lucy E; Montgomery, Alan A; Thomas, Kim S; Brown, Sara J; Ridd, Matthew J; Lawton, Sandra; Simpson, Eric L; Cork, Michael J; Sach, Tracey H; Flohr, Carsten; Mitchell, Eleanor J; Swinden, Richard; Tarr, Stella; Davies-Jones, Susan; Jay, Nicola; Kelle... Journal: Lancet Issue: Volume 395:Issue 10228(2020) Page Start: 962 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10356 (17th September 2022) Authors: Paller, Amy S; Simpson, Eric L; Siegfried, Elaine C; Cork, Michael J; Wollenberg, Andreas; Arkwright, Peter D; Soong, Weily; Gonzalez, Mercedes E; Schneider, Lynda C; Sidbury, Robert; Lockshin, Benjamin; Meltzer, Steven; Wang, Zhixiao; Mannent, Leda P; Amin, Nikhil; Sun, Yiping; Laws, Elizabeth; ... Journal: Lancet Issue: Volume 400:Issue 10356(2022) Page Start: 908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Issue 10246 (25th July 2020) Authors: Simpson, Eric L; Sinclair, Rodney; Forman, Seth; Wollenberg, Andreas; Aschoff, Roland; Cork, Michael; Bieber, Thomas; Thyssen, Jacob P; Yosipovitch, Gil; Flohr, Carsten; Magnolo, Nina; Maari, Catherine; Feeney, Claire; Biswas, Pinaki; Tatulych, Svitlana; Valdez, Hernan; Rojo, Ricardo Journal: Lancet Issue: Volume 396:Issue 10246(2020) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Issue 10013 (2nd January 2016) Authors: Thaçi, Diamant; Simpson, Eric L; Beck, Lisa A; Bieber, Thomas; Blauvelt, Andrew; Papp, Kim; Soong, Weily; Worm, Margitta; Szepietowski, Jacek C; Sofen, Howard; Kawashima, Makoto; Wu, Richard; Weinstein, Steven P; Graham, Neil M H; Pirozzi, Gianluca; Teper, Ariel; Sutherland, E Rand; Mastey, Vera;... Journal: Lancet Issue: Volume 387:Issue 10013(2016) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. International observational atopic dermatitis cohort to follow natural history and treatment course: TARGET-DERM AD study design and rationale. Issue 11 (27th November 2020) Authors: Abuabara, Katrina; Silverberg, Jonathan I; Simpson, Eric L; Paller, Amy S; Eichenfield, Lawrence F.; Bissonnette, Robert; Krueger, James; Harris, John E.; Dalfonso, Laura; Watkins, Stephanie E; Crawford, Julie M; Thaçi, D; Guttman-Yassky, Emma Journal: BMJ open Issue: Volume 10:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗